Search Results - "Kapuśniak, A."

Filling the gap in CNS drug development: evaluation of the role of drug repurposing by Caban, A., Pisarczyk, K., Kopacz, K., Kapuśniak, A., Toumi, M., Rémuzat, C., Kornfeld, A.

“…Background and objective: Background and objective: Drug repurposing has been considered a cost-effective and reduced-risk strategy for developing new drugs…”
Get full text

European Initiatives To Enhance Biosimilar Adoption by Kapuśniak, A, Rémuzat, C, Toumi, M

“…OBJECTIVES: European Union (EU) is the most advanced biosimilar market, with 28 products already authorised. Since establishment of the regulatory pathway for…”
Get full text

HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception by Tyrała-Chowaniec, I., Kapuśniak, A, Wilk, M, Caban, A

Get full text

HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US by Wilk, M, Kapuśniak, A, Tyrała-Chowaniec, I, Caban, A

Get full text

Clinical effect of torsemide in a horse with congestive heart failure and atrial fibrillation by Ferlini Agne, G., Kapusniak, A.E., Wooldridge, A.A., Jung, S.W.

“…•Torsemide was absorbed orally and achieved therapeutic plasma concentrations.•Severe hypokalaemia was observed after administration of a high dose of…”
Get full text

PHP61 - European Initiatives To Enhance Biosimilar Adoption by Kapuśniak, A, Rémuzat, C, Toumi, M

Get full text

PHP40 - Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act? by Jaros, P, Kapuśniak, A, Kornfeld, Å

Get full text

Has Access To Innovative Therapies In Poland Improved Following The 2012 Reimbursement Act? by Jaros, P, Kapuśniak, A, Kornfeld, Å

Get full text

PHP63 - MEASURES TO FIGHT ILLEGAL EXPORT CAUSING DRUGS SHORTAGES IN POLAND by Kapuśniak, A., Caban, A., Rémuzat, C., Toumi, M.

Get full text

PHP152 - MECHANISMS OF ILLEGAL EXPORT CAUSING DRUGS SHORTAGES IN POLAND by Kapuśniak, A., Caban, A., Rémuzat, C., Toumi, M.

Get full text

PIN12 MARKET ACCESS PATHWAYS FOR VACCINES IN EU: THE NEED FOR MORE TRANSPARENT & COLLABORATIVE FRAMEWORK IN A CONTEXT OF EU28 TO DECREASE UNCERTAINTY AND ALLOW FASTER PATIENT ACCESS by Kapuśniak, A., Rémuzat, C., Laigle, V., Beck, E., Visic, A., Toumi, M.

Get full text

PBI37 BIOSIMILAR INTERCHANGEABILITY, SUBSTITUTION AND SWITCHING: AN OVERVIEW OF 5 EUROPEAN MEMBER STATES AND THE UNITED STATES by Zapała, A., Kapuśniak, A., Sroka, A., Lach, S., Rémuzat, C., Toumi, M.

Get full text

PHP116 - Biosimilars: Which Value For Society? by Rémuzat, C, Kapuśniak, A, Lach, S, Dziwisz, M, Toumi, M

Get full text

Biosimilars: Which Value For Society? by Rémuzat, C, Kapuśniak, A, Lach, S, Dziwisz, M, Toumi, M

Get full text

Supply-Side and Demand-Side Policies for Biosimilars: An Overview in 10 European Member States by Rémuzat, C, Kapuśniak, A, Caban, A, Ionescu, D, Radière, G, Mendoza, C, Toumi, M

Get full text

PHP321 - Supply-Side and Demand-Side Policies for Biosimilars: An Overview in 10 European Member States by Rémuzat, C, Kapuśniak, A, Caban, A, Ionescu, D, Radière, G, Mendoza, C, Toumi, M

Get full text

PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland by Fedyna, M, Mucha, A, Kapusniak, A, Bebrysz, M, Rutkowski, J, Schubert, A, Skrzekowska-Baran, I, Rys, P

Get full text

PIN138 National and European Union-LEVEL Recommendations to Accelerate Vaccine Timely Access by Kapusniak, A., Rémuzat, C., Laigle, V., Beck, E., Toumi, M.

Get full text

PIN140 Drivers and Barriers to Vaccines Timely Access to Population in Europe: Perspectives from Experts Knowlegable of the Decision-Making Process by Kapusniak, A., Rémuzat, C., Laigle, V., Beck, E., Toumi, M.

Get full text

PIN113 EU MARKET ACCESS PATHWAYS FOR VACCINES: DEFINITION OF COUNTRY ARCHETYPES USING MATHEMATICAL CLUSTERING by Kapusniak, A., Rémuzat, C., Laigle, V., Beck, E., Visic, A., Toumi, M.

Get full text